Clinical Trial Update: Delta-THC in Dementia [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating delta-THC for behavioral disturbances and pain in dementia patients has completed. The study included Alzheimer's disease and vascula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia
• Vascular Dementia

Drugs mentioned

• Delta-THC (Delta-9-tetrahydrocannabinol)

Snippet

Sponsor: Radboud University Medical Center | Conditions: Behavioural Disturbances, Pain | Phase 2 | Status: COMPLETED